US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist

15.535
-2.875-15.62%

Trading May 23 14:46 ET

396.68MMarket Cap-1256P/E (TTM)

LENZ Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

15M

Operating revenue

--0

--15M

--0

Cost of revenue

Gross profit

Operating expense

27.52%16.09M

184.22%72.43M

173.79%24.99M

12.62M

280.68%25.48M

9.13M

6.69M

Selling and administrative expenses

142.30%5.55M

196.58%12.93M

264.26%5.45M

--2.29M

76.15%4.36M

--1.5M

--2.47M

Research and development costs

2.05%10.54M

181.68%59.5M

156.04%19.54M

--10.33M

400.59%21.13M

--7.63M

--4.22M

Operating profit

-27.52%-16.09M

-590.92%-72.43M

-173.79%-24.99M

-12.62M

-56.60%-10.48M

-9.13M

-6.69M

Net non-operating interest income expense

788K

2.19M

Non-operating interest income

--788K

--2.19M

----

--0

----

Other net income (expense)

-2,396.30%-1.35M

389.47%93K

-107,200.00%-1.07M

-54K

102.19%19K

-869K

Other non- operating income (expenses)

-2,396.30%-1.35M

389.47%93K

-107,200.00%-1.07M

---54K

102.19%19K

--1K

---869K

Income before tax

-31.40%-16.65M

-570.37%-70.15M

-161.57%-23.87M

-12.67M

-38.36%-10.46M

-9.13M

-7.56M

Income tax

-151.59%-179K

-159.08%-179K

347K

303K

Net income

-31.40%-16.65M

-547.19%-69.97M

-151.27%-23.69M

-12.67M

-42.95%-10.81M

-9.43M

-7.56M

Net income continuous Operations

-31.40%-16.65M

-547.19%-69.97M

-151.27%-23.69M

---12.67M

-42.95%-10.81M

---9.43M

---7.56M

Minority interest income

Net income attributable to the parent company

-31.40%-16.65M

-547.19%-69.97M

-151.27%-23.69M

-12.67M

-42.95%-10.81M

-9.43M

-7.56M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-31.40%-16.65M

-547.19%-69.97M

-151.27%-23.69M

-12.67M

-42.95%-10.81M

-9.43M

-7.56M

Basic earnings per share

-611.39%-3.53

-547.19%-2.7402

-151.27%-0.9279

-0.4962

-42.95%-0.4234

-0.3693

-0.2962

Diluted earnings per share

-611.39%-3.53

-547.19%-2.7402

-151.27%-0.9279

-0.4962

-42.95%-0.4234

-0.3693

-0.2962

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	0	0	0	0	15M	0	0
Operating revenue	--0	--0	--0	--0	--15M	--0	--0
Cost of revenue
Gross profit
Operating expense	27.52%16.09M	184.22%72.43M	173.79%24.99M	12.62M	280.68%25.48M	9.13M	6.69M
Selling and administrative expenses	142.30%5.55M	196.58%12.93M	264.26%5.45M	--2.29M	76.15%4.36M	--1.5M	--2.47M
Research and development costs	2.05%10.54M	181.68%59.5M	156.04%19.54M	--10.33M	400.59%21.13M	--7.63M	--4.22M
Operating profit	-27.52%-16.09M	-590.92%-72.43M	-173.79%-24.99M	-12.62M	-56.60%-10.48M	-9.13M	-6.69M
Net non-operating interest income expense	788K	2.19M		0
Non-operating interest income	--788K	--2.19M	----	--0	----	----	----
Other net income (expense)	-2,396.30%-1.35M	389.47%93K	-107,200.00%-1.07M	-54K	102.19%19K	1K	-869K
Other non- operating income (expenses)	-2,396.30%-1.35M	389.47%93K	-107,200.00%-1.07M	---54K	102.19%19K	--1K	---869K
Income before tax	-31.40%-16.65M	-570.37%-70.15M	-161.57%-23.87M	-12.67M	-38.36%-10.46M	-9.13M	-7.56M
Income tax		-151.59%-179K	-159.08%-179K		347K	303K	0
Net income	-31.40%-16.65M	-547.19%-69.97M	-151.27%-23.69M	-12.67M	-42.95%-10.81M	-9.43M	-7.56M
Net income continuous Operations	-31.40%-16.65M	-547.19%-69.97M	-151.27%-23.69M	---12.67M	-42.95%-10.81M	---9.43M	---7.56M
Minority interest income
Net income attributable to the parent company	-31.40%-16.65M	-547.19%-69.97M	-151.27%-23.69M	-12.67M	-42.95%-10.81M	-9.43M	-7.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-31.40%-16.65M	-547.19%-69.97M	-151.27%-23.69M	-12.67M	-42.95%-10.81M	-9.43M	-7.56M
Basic earnings per share	-611.39%-3.53	-547.19%-2.7402	-151.27%-0.9279	-0.4962	-42.95%-0.4234	-0.3693	-0.2962
Diluted earnings per share	-611.39%-3.53	-547.19%-2.7402	-151.27%-0.9279	-0.4962	-42.95%-0.4234	-0.3693	-0.2962
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall